CN105287666A - 一种沙棘籽油的制备方法 - Google Patents
一种沙棘籽油的制备方法 Download PDFInfo
- Publication number
- CN105287666A CN105287666A CN201510874833.5A CN201510874833A CN105287666A CN 105287666 A CN105287666 A CN 105287666A CN 201510874833 A CN201510874833 A CN 201510874833A CN 105287666 A CN105287666 A CN 105287666A
- Authority
- CN
- China
- Prior art keywords
- seed oil
- oil
- fructrs hippophae
- hippophae seed
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 151
- 238000000034 method Methods 0.000 title claims abstract description 52
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title abstract description 7
- 240000000950 Hippophae rhamnoides Species 0.000 title description 3
- 241000229143 Hippophae Species 0.000 claims abstract description 156
- 235000019198 oils Nutrition 0.000 claims abstract description 54
- 238000000605 extraction Methods 0.000 claims abstract description 34
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 25
- 238000001816 cooling Methods 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 5
- 235000003935 Hippophae Nutrition 0.000 claims description 152
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 57
- 239000003921 oil Substances 0.000 claims description 53
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 30
- 239000000839 emulsion Substances 0.000 claims description 25
- 210000003022 colostrum Anatomy 0.000 claims description 24
- 235000021277 colostrum Nutrition 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 24
- 239000012071 phase Substances 0.000 claims description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 239000008346 aqueous phase Substances 0.000 claims description 20
- 230000018044 dehydration Effects 0.000 claims description 20
- 238000006297 dehydration reaction Methods 0.000 claims description 20
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000008215 water for injection Substances 0.000 claims description 17
- 229910052799 carbon Inorganic materials 0.000 claims description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 claims description 12
- 238000000199 molecular distillation Methods 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000001802 infusion Methods 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 7
- 239000010779 crude oil Substances 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 238000013019 agitation Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000009833 condensation Methods 0.000 claims description 6
- 230000005494 condensation Effects 0.000 claims description 6
- 238000004332 deodorization Methods 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- 239000006200 vaporizer Substances 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 150000004668 long chain fatty acids Chemical group 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- 239000002738 chelating agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000008157 edible vegetable oil Substances 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 239000012670 alkaline solution Substances 0.000 claims description 2
- 238000005138 cryopreservation Methods 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 239000008347 soybean phospholipid Substances 0.000 claims description 2
- 239000000287 crude extract Substances 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- 230000001877 deodorizing effect Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 10
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 9
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 7
- -1 aliphatic alcohols Chemical class 0.000 description 7
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000000711 cancerogenic effect Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- IRIAEXORFWYRCZ-UHFFFAOYSA-N Butylbenzyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IRIAEXORFWYRCZ-UHFFFAOYSA-N 0.000 description 4
- 231100000315 carcinogenic Toxicity 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 231100000025 genetic toxicology Toxicity 0.000 description 3
- 230000001738 genotoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 208000031320 Teratogenesis Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- MGWAVDBGNNKXQV-UHFFFAOYSA-N diisobutyl phthalate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C MGWAVDBGNNKXQV-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000008175 fetal development Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 102100035474 DNA polymerase kappa Human genes 0.000 description 1
- 101710108091 DNA polymerase kappa Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical compound CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001779 embryotoxic effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- DJDSLBVSSOQSLW-UHFFFAOYSA-N mono(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(O)=O DJDSLBVSSOQSLW-UHFFFAOYSA-N 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000003614 peroxisome proliferator Substances 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003021 phthalic acid derivatives Chemical class 0.000 description 1
- 150000003022 phthalic acids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 231100000205 reproductive and developmental toxicity Toxicity 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Edible Oils And Fats (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
样品 | pH | 平均粒径(nm) | PDI | >5μm乳滴(%) |
实施例2 | 7.21 | 250.1 | 0.041 | 0.01 |
实施例3 | 7.36 | 246.3 | 0.043 | 0.01 |
实施例4 | 7.28 | 245.3 | 0.095 | 0.01 |
实施例5 | 7.43 | 267.8 | 0.067 | 0.02 |
实施例6 | 7.32 | 246.9 | 0.080 | 0.01 |
实施例7 | 7.37 | 255.3 | 0.092 | 0.01 |
样品 | pH | 平均粒径(nm) | PDI | >5μm乳滴(%) |
实施例2 | 7.25 | 253.7 | 0.050 | 0.01 |
实施例3 | 7.40 | 250.8 | 0.052 | 0.01 |
实施例4 | 7.32 | 249.2 | 0.105 | 0.01 |
实施例5 | 7.49 | 273.6 | 0.075 | 0.02 |
实施例6 | 7.47 | 252.5 | 0.096 | 0.01 |
实施例7 | 7.51 | 260.4 | 0.101 | 0.01 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510874833.5A CN105287666B (zh) | 2015-12-02 | 2015-12-02 | 一种沙棘籽油的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510874833.5A CN105287666B (zh) | 2015-12-02 | 2015-12-02 | 一种沙棘籽油的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105287666A true CN105287666A (zh) | 2016-02-03 |
CN105287666B CN105287666B (zh) | 2019-03-19 |
Family
ID=55185953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510874833.5A Active CN105287666B (zh) | 2015-12-02 | 2015-12-02 | 一种沙棘籽油的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105287666B (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106136243A (zh) * | 2016-08-26 | 2016-11-23 | 李仁宝 | 一种海藻提取物保健软胶囊 |
CN106265785A (zh) * | 2016-08-12 | 2017-01-04 | 张掖市润星生物科技有限公司 | 一种沙棘抑郁症胶囊及其生产工艺 |
CN106900885A (zh) * | 2017-02-27 | 2017-06-30 | 山东省科学院生物研究所 | 一种微囊化牡丹籽油、复配组合物及其制备方法 |
CN107156332A (zh) * | 2017-06-22 | 2017-09-15 | 利康行(北京)生物科技有限公司 | 一种增强免疫力的复方保健品 |
EP3315174A1 (en) * | 2016-11-01 | 2018-05-02 | Aromtech Ltd | Seed oil, composition comprising seed oil and use of seed oil |
CN108998222A (zh) * | 2018-09-26 | 2018-12-14 | 吉林化工学院 | 一种具有抑菌活性的沙棘籽油的制备工艺 |
CN109097189A (zh) * | 2018-09-21 | 2018-12-28 | 青海净草生物科技有限公司 | 一种藏沙棘籽油萃取及制备方法 |
CN109628215A (zh) * | 2018-12-28 | 2019-04-16 | 绍兴天康生物科技有限公司 | 一种富含天然藏花酸的栀子油的提炼方法和应用 |
CN109880688A (zh) * | 2017-12-06 | 2019-06-14 | 丰益(上海)生物技术研发中心有限公司 | 低塑化剂或无塑化剂的油脂的制备方法 |
CN112156053A (zh) * | 2020-10-22 | 2021-01-01 | 北京中康联健康科技有限公司 | 一种欧洲越桔水光组合物及其制备方法 |
CN112251284A (zh) * | 2020-10-11 | 2021-01-22 | 甘肃省科学院生物研究所 | 一种沙棘全果油的提取、精制方法 |
CN112251286A (zh) * | 2020-11-17 | 2021-01-22 | 江苏鸿祺生物科技有限公司 | 一种高品质沙棘籽油及其萃取工艺 |
CN116747554A (zh) * | 2023-08-11 | 2023-09-15 | 烟台载物生物科技有限公司 | 一种海参肽生产萃取装置 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102533433A (zh) * | 2012-01-30 | 2012-07-04 | 刘正芳 | 一种超临界萃取沙棘油的方法 |
CN104178337A (zh) * | 2014-05-05 | 2014-12-03 | 中粮屯河股份有限公司 | 一种分离沙棘籽油中邻苯二甲酸酯类的方法 |
-
2015
- 2015-12-02 CN CN201510874833.5A patent/CN105287666B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102533433A (zh) * | 2012-01-30 | 2012-07-04 | 刘正芳 | 一种超临界萃取沙棘油的方法 |
CN104178337A (zh) * | 2014-05-05 | 2014-12-03 | 中粮屯河股份有限公司 | 一种分离沙棘籽油中邻苯二甲酸酯类的方法 |
Non-Patent Citations (1)
Title |
---|
杨明明: "沙棘籽油脂肪乳注射液的研究", 《中国优秀硕士论文全文数据库 医药卫生科技辑》 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106265785A (zh) * | 2016-08-12 | 2017-01-04 | 张掖市润星生物科技有限公司 | 一种沙棘抑郁症胶囊及其生产工艺 |
CN106136243A (zh) * | 2016-08-26 | 2016-11-23 | 李仁宝 | 一种海藻提取物保健软胶囊 |
EP3315174A1 (en) * | 2016-11-01 | 2018-05-02 | Aromtech Ltd | Seed oil, composition comprising seed oil and use of seed oil |
CN106900885A (zh) * | 2017-02-27 | 2017-06-30 | 山东省科学院生物研究所 | 一种微囊化牡丹籽油、复配组合物及其制备方法 |
CN107156332A (zh) * | 2017-06-22 | 2017-09-15 | 利康行(北京)生物科技有限公司 | 一种增强免疫力的复方保健品 |
CN109880688A (zh) * | 2017-12-06 | 2019-06-14 | 丰益(上海)生物技术研发中心有限公司 | 低塑化剂或无塑化剂的油脂的制备方法 |
CN109097189A (zh) * | 2018-09-21 | 2018-12-28 | 青海净草生物科技有限公司 | 一种藏沙棘籽油萃取及制备方法 |
CN108998222A (zh) * | 2018-09-26 | 2018-12-14 | 吉林化工学院 | 一种具有抑菌活性的沙棘籽油的制备工艺 |
CN109628215A (zh) * | 2018-12-28 | 2019-04-16 | 绍兴天康生物科技有限公司 | 一种富含天然藏花酸的栀子油的提炼方法和应用 |
CN109628215B (zh) * | 2018-12-28 | 2022-02-15 | 绍兴天康生物科技有限公司 | 一种富含天然藏花酸的栀子油的提炼方法和应用 |
CN112251284A (zh) * | 2020-10-11 | 2021-01-22 | 甘肃省科学院生物研究所 | 一种沙棘全果油的提取、精制方法 |
CN112156053A (zh) * | 2020-10-22 | 2021-01-01 | 北京中康联健康科技有限公司 | 一种欧洲越桔水光组合物及其制备方法 |
CN112251286A (zh) * | 2020-11-17 | 2021-01-22 | 江苏鸿祺生物科技有限公司 | 一种高品质沙棘籽油及其萃取工艺 |
CN112251286B (zh) * | 2020-11-17 | 2021-05-28 | 江苏鸿祺生物科技有限公司 | 一种沙棘籽油及其萃取工艺 |
CN116747554A (zh) * | 2023-08-11 | 2023-09-15 | 烟台载物生物科技有限公司 | 一种海参肽生产萃取装置 |
CN116747554B (zh) * | 2023-08-11 | 2023-11-24 | 烟台载物生物科技有限公司 | 一种海参肽生产萃取装置 |
Also Published As
Publication number | Publication date |
---|---|
CN105287666B (zh) | 2019-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105287666A (zh) | 一种沙棘籽油的制备方法 | |
US11819491B2 (en) | Dilutable formulations of cannabinoids and processes for their preparation | |
KR20190084036A (ko) | 식물 공급원으로부터 칸나비노이드의 선택적 추출 방법 | |
US20120171186A1 (en) | method for producing a nutraceutical composition and the nutraceutical produced by the method | |
CN102247420B (zh) | 一种墨旱莲提取物的制备方法及用途 | |
CN104498180B (zh) | 一种从南极磷虾油中提取高纯度磷脂的方法 | |
CN1813782B (zh) | 一种银杏达莫组合物、含有该组合物的药物及其制备方法 | |
US20220233465A1 (en) | Cannabinoid-comprising compositions for management of pain | |
CN103830204A (zh) | 一种含水飞蓟提取物的软胶囊及其制备方法 | |
JP2000191525A (ja) | 皮膚外用剤組成物 | |
CN106491420A (zh) | 富含油茶主要成分的唇膏及其制备方法 | |
JPH0873396A (ja) | 天然メナキノン−7高含量脂質 | |
CN106722444A (zh) | 一种沙棘咀嚼片的制作方法 | |
EP1843775A1 (en) | Novel composition comprising ligustilide and process for their manufacture | |
JP2002346575A (ja) | 残留塩素除去剤 | |
JP2005104962A (ja) | 皮膚外用剤 | |
Beyzi et al. | Sterol profile of some medicinal and aromatic plant oils: effect of silyl derivatization process | |
CN104689328B (zh) | 谷维素组合物 | |
JP4320798B2 (ja) | 肝油、精製方法および用途 | |
CN103271955B (zh) | 鸦胆子油乳组合物 | |
CN104524583B (zh) | 人造乳糜载药组合物及其制备方法与用途 | |
WO2023054477A1 (ja) | アロエ抽出物の製造方法 | |
US20230219015A1 (en) | Extraction method and mixture of substances | |
CN107669720A (zh) | 复方人参破壁灵芝孢子粉微囊及其制备方法 | |
CN106551920B (zh) | 一种多元番茄红素磷脂复合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 100176 Beijing Beijing economic and Technological Development Zone, Chuang Chuang thirteen Street 31 hospital two District 7 Building 101 room. Applicant after: Beijing nukangda medicine Polytron Technologies Inc Address before: 100085 B318 5, Beijing, Haidian District. Applicant before: BEIJING NUOKANGDA PHARMACEUTICAL CO., LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201111 Address after: Plot 0501-57-4, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing 100176 Patentee after: Beijing Connaught Pharmaceutical Co., Ltd. Address before: 100176 Beijing Beijing economic and Technological Development Zone, Chuang Chuang thirteen Street 31 hospital two District 7 Building 101 room. Patentee before: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210625 Address after: 100176 Room 101, building 7, area 2, yard 31, Kechuang 13th Street, economic and Technological Development Zone, Daxing District, Beijing Patentee after: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. Address before: Plot 0501-57-4, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing 100176 Patentee before: Beijing Connaught Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210810 Address after: 100176 room 108, first floor, building 7, zone 2, No. 31, Kechuang 13th Street, economic and Technological Development Zone, Daxing District, Beijing (Yizhuang group, high-end industrial area of Beijing Pilot Free Trade Zone) Patentee after: Beijing nuobao Nutrition Technology Co.,Ltd. Address before: 100176 Room 101, building 7, area 2, yard 31, Kechuang 13th Street, economic and Technological Development Zone, Daxing District, Beijing Patentee before: Beijing Nuokangda Pharmaceutical Technology Co.,Ltd. |